The Europe GMP cell therapy consumables market is expected to grow from US$ 4,827.85 million in 2022 to US$ 20,569.16 million by 2028; it is estimated to grow at a CAGR of 27.2% from 2022 to 2028.
Moreover, numerous biotechnology companies operating in the GMP cell therapy consumables market are collaborating to accelerate R&D activities on a global level. For instance, in October 2022, Century Therapeutics and Bristol Myers Squibb announced the research collaboration and license agreement to develop and commercialize up to four induced pluripotent stem cells (“iPSC”) derived, engineered natural killer cell (“iNK”) and/or T cell (“iT”) programs for hematologic malignancies and solid tumors. Additionally, the rising demand for personalized and regenerative medicine has boosted the growth of the cell therapy consumables market. Thus, an increase in research & development activities along with a surge in drug discovery has tremendously increased the use of GMP cell therapy consumables, which is driving the growth of the GMP cell therapy consumables market across the region.
Further, there have been remarkable innovations in the cell therapy segment in Germany. For instance, in 2021, Germany’s Federal Institute for Vaccines and Biomedicines (Paul-Ehrlich-Institut) granted RHEACELL national approval for its cell therapy product - AMESANAR - for use in patients having chronic wounds. Similarly, in June 2022, Bayer’s BlueRock Therapeutics established a European site for cell therapy innovation. BlueRock is currently engaged in a Phase I clinical trial for its novel cell therapy, BRT-DA01, for treating Parkinson’s disease. The rising government health expenditure, growing expansion of global players in Germany, and increasing product development by manufacturers are boosting the application of GMP cell therapy consumables, which is also boosting the growth of the Europe GMP cell therapy consumables market.
Rise in Research & Development and Drug Discovery Drives Europe GMP Cell Therapy Consumables Market
Drug discovery is a long process that comprises various steps such as early discovery, preclinical phase, clinical phase, and regulatory approval. The process tremendously involves the use of cell therapy consumables to achieve the desired results. According to the World Health Organization, ~10 million deaths due to cancer were recorded in 2020, and the most common types of cancer are breast cancer, lung cancer, colon cancer, rectum cancer, and prostate cancer. Various research studies have shown positive outcomes of drugs that can effectively treat cancer, neurological disorders, autoimmune disorders, and other chronic disorders. Therefore, the rising prevalence of chronic disorders propels the demand for research and development(R&D) activities. In addition, the growing incidence of various rare disorders such as amyloidosis, Adrenoleukodystrophy, and Ehlers-Danlos syndrome has increased the R&D activities for drug development.Moreover, numerous biotechnology companies operating in the GMP cell therapy consumables market are collaborating to accelerate R&D activities on a global level. For instance, in October 2022, Century Therapeutics and Bristol Myers Squibb announced the research collaboration and license agreement to develop and commercialize up to four induced pluripotent stem cells (“iPSC”) derived, engineered natural killer cell (“iNK”) and/or T cell (“iT”) programs for hematologic malignancies and solid tumors. Additionally, the rising demand for personalized and regenerative medicine has boosted the growth of the cell therapy consumables market. Thus, an increase in research & development activities along with a surge in drug discovery has tremendously increased the use of GMP cell therapy consumables, which is driving the growth of the GMP cell therapy consumables market across the region.
Europe GMP Cell Therapy Consumables Market Overview
The Europe GMP cell therapy consumables market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant share of the global GMP cell therapy consumables market. The market growth in the region is due to increasing healthcare expenditure, rising incidence of cancer, increasing health awareness, and growing research and development. Germany is considered among the fastest-growing GMP cell therapy consumables market in Europe. The growing importance of GMP cell therapy consumables, along with the expansion of regional players, is aiding the market growth in Germany. Further, The Federal Statistical Office reported an increase in health expenditure in Germany which aids in research and development in the healthcare sector. According to German Trade and Invest (GTAI), Germany's biotech industry has been rapidly expanding for some years. On average, more than 710 companies are engaged in the biotechnology sector. Overall, the biotech sector revenue is increased by 36%, while R&D spending has increased by 37%. Germany has experienced a growth in the number of innovative pharmaceutical companies, drug manufacturers, contract research organizations (CROs), and small- and medium-sized biopharmaceutical companies.Further, there have been remarkable innovations in the cell therapy segment in Germany. For instance, in 2021, Germany’s Federal Institute for Vaccines and Biomedicines (Paul-Ehrlich-Institut) granted RHEACELL national approval for its cell therapy product - AMESANAR - for use in patients having chronic wounds. Similarly, in June 2022, Bayer’s BlueRock Therapeutics established a European site for cell therapy innovation. BlueRock is currently engaged in a Phase I clinical trial for its novel cell therapy, BRT-DA01, for treating Parkinson’s disease. The rising government health expenditure, growing expansion of global players in Germany, and increasing product development by manufacturers are boosting the application of GMP cell therapy consumables, which is also boosting the growth of the Europe GMP cell therapy consumables market.
Europe GMP Cell Therapy Consumables Market Segmentation
The Europe GMP cell therapy consumables market is segmented on the basis of product, cell therapy, process, end use, and country.- Based on product, the GMP cell therapy consumables market is segmented into kits, reagents/molecular biology reagents, growth factors/cytokines and interleukins (including protein and nucleic acid purification buffers), and others. The kits segment held the largest share of the Europe GMP cell therapy consumables market in 2022.
- Based on cell therapy, the GMP cell therapy consumables market is segmented into NK cell therapy, stem cell therapy, T-cell therapy, and others. The T-cell therapy segment registered the largest share of the Europe GMP cell therapy consumables market in 2022. Based on process, the market is segmented into cell collection and characterization/sorting and separation, cell culture and expansion/preparation, cryopreservation, cell processing and formulation, cell isolation and activation, cell distribution/handling, process monitoring and control/readministration/quality assurance, and others. The cell collection and characterization/sorting and separation segment held the largest share of the Europe GMP cell therapy consumables market in 2022. Based on end use, the market is segmented into clinical, commercial, and research. The clinical segment held the largest share of the Europe GMP cell therapy consumables market in 2022. Based on country, the Europe GMP cell therapy consumables market is segmented into France, Italy, Germany, Spain, the UK, and the Rest of Europe. Germany dominated the Europe GMP cell therapy consumables market in 2022. Bio-Techne Corp, BPS Bioscience Inc, Corning Inc, FUJIFILM Irvine Scientific Inc, Global Life Sciences Solutions USA LLC, Lonza Group AG, Merck KGaA, Miltenyi Biotec BV & Co KG, Sartorius AG, and Thermo Fisher Scientific Inc are the leading companies operating in the Europe cell therapy consumables market.
Table of Contents
1. Introduction1.1 Study Scope
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe GMP Cell Therapy Consumables Market - by Product
1.3.2 Europe GMP Cell Therapy Consumables Market - by Cell Therapy
1.3.3 Europe GMP Cell Therapy Consumables Market - by End Use
1.3.4 Europe GMP Cell Therapy Consumables Market - by End Use
1.3.5 Europe GMP Cell Therapy Consumables Market - by Country
2. Europe GMP Cell Therapy Consumables Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe GMP Cell Therapy Consumables Market - Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Experts’ Opinion
5. Europe GMP Cell Therapy Consumables Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rise in Research & Development and Drug Discovery
5.1.2 Increase in Strategic Collaborations
5.2 Market Restraints
5.2.1 Stringent Regulatory Policies
5.3 Future Trends
5.3.1 Increasing Clinical Trials and Rising GMP Demand
5.4 Impact Analysis
6. GMP Cell Therapy Consumables Market - Europe Analysis
6.1 Europe GMP Cell Therapy Consumables Market Revenue Forecast and Analysis
7. Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 - by Product
7.1 Overview
7.2 Europe GMP Cell Therapy Consumables Market Revenue Share, by Product 2021 & 2028 (%)
7.3 Kits
7.3.1 Overview
7.3.2 Kits: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Reagents/ Molecular Biology Reagents
7.4.1 Overview
7.4.2 Reagents/ Molecular Biology Reagents: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Growth Factors/Cytokines and Interleukins (Including Protein and Nucleic Acid Purification Buffers)
7.5.1 Overview
7.5.2 Growth Factors/Cytokines and Interleukins (Including Protein and Nucleic Acid Purification Buffers): Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
8. Europe GMP Cell Therapy Consumables Market Analysis and Forecasts to 2028 - by Cell Therapy
8.1 Overview
8.2 Europe GMP Cell Therapy Consumables Market, by Cell Therapy 2021 & 2028 (%)
8.3 NK Cell Therapy
8.3.1 Overview
8.3.2 NK Cell Therapy: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Stem Cell Therapy
8.4.1 Overview
8.4.2 Stem Cell Therapy: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
8.5 T-cell Therapy
8.5.1 Overview
8.5.2 T-cell Therapy: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
9. Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 - by End Use
9.1 Overview
9.2 Europe GMP Cell Therapy Consumables Market Revenue Share, by End User 2021 & 2028 (%)
9.3 Clinical
9.3.1 Overview
9.3.2 Clinical: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Commercial
9.4.1 Overview
9.4.2 Commercial: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Research
9.5.1 Overview
9.5.2 Research: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
10. Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 - by Process
10.1 Overview
10.2 Europe GMP Cell Therapy Consumables Market Revenue Share, by End User 2021 & 2028 (%)
10.3 Cell Collection and Characterization/Sorting and Separation
10.3.1 Overview
10.3.2 Cell Collection and Characterization/ Sorting and Separation: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
10.4 Cell Culture and Expansion/Preparation
10.4.1 Overview
10.4.2 Cell Culture and Expansion/Preparation: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
10.5 Cryopreservation
10.5.1 Overview
10.5.2 Cryopreservation: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
10.6 Cell Processing and Formulation
10.6.1 Overview
10.6.2 Cell Processing and Formulation: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
10.7 Cell Isolation and Activation
10.7.1 Overview
10.7.2 Cell Isolation and Activation: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
10.8 Cell Distribution/Handling
10.8.1 Overview
10.8.2 Cell Distribution/Handling: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
10.9 Process Monitoring and Control/Readministration/Quality Assurance
10.9.1 Overview
10.9.2 Process Monitoring and Control/Readministration/Quality Assurance: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
10.10 Other
10.10.1 Overview
10.10.2 Other: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
11. Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 - Country Analysis
11.1 Overview
11.1.1 Europe: GMP Cell Therapy Consumables Market, by Country, 2021 & 2028 (%)
11.1.1.1 Germany: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.1 Overview
11.1.1.1.2 Germany: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.3 Germany: GMP Cell Therapy Consumables Market, by Product, 2019-2028 (US$ Million)
11.1.1.1.4 Germany: GMP Cell Therapy Consumables Market, by Cell Therapy, 2019-2028 (US$ Million)
11.1.1.1.5 Germany: GMP Cell Therapy Consumables Market, by End Use, 2019-2028 (US$ Million)
11.1.1.1.6 Germany: GMP Cell Therapy Consumables Market, by Process, 2019-2028 (US$ Million)
11.1.1.2 UK: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.1 Overview
11.1.1.2.2 UK: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.3 UK: GMP Cell Therapy Consumables Market, by Product, 2019-2028 (US$ Million)
11.1.1.2.4 UK: GMP Cell Therapy Consumables Market, by Cell Therapy, 2019-2028 (US$ Million)
11.1.1.2.5 UK: GMP Cell Therapy Consumables Market, by End Use, 2019-2028 (US$ Million)
11.1.1.2.6 UK: GMP Cell Therapy Consumables Market, by Process, 2019-2028 (US$ Million)
11.1.1.3 France: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.1 Overview
11.1.1.3.2 France: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.3 France: GMP Cell Therapy Consumables Market, by Product, 2019-2028 (US$ Million)
11.1.1.3.4 France: GMP Cell Therapy Consumables Market, by Cell Therapy, 2019-2028 (US$ Million)
11.1.1.3.5 France: GMP Cell Therapy Consumables Market, by End Use, 2019-2028 (US$ Million)
11.1.1.3.6 France: GMP Cell Therapy Consumables Market, by Process, 2019-2028 (US$ Million)
11.1.1.4 Italy: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.4.1 Overview
11.1.1.4.2 Italy: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.4.3 Italy: GMP Cell Therapy Consumables Market, by Product, 2019-2028 (US$ Million)
11.1.1.4.4 Italy: GMP Cell Therapy Consumables Market, by Cell Therapy, 2019-2028 (US$ Million)
11.1.1.4.5 Italy: GMP Cell Therapy Consumables Market, by End Use, 2019-2028 (US$ Million)
11.1.1.4.6 Italy: GMP Cell Therapy Consumables Market, by Process, 2019-2028 (US$ Million)
11.1.1.5 Spain: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.5.1 Overview
11.1.1.5.2 Spain: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.5.3 Spain: GMP Cell Therapy Consumables Market, by Product, 2019-2028 (US$ Million)
11.1.1.5.4 Spain: GMP Cell Therapy Consumables Market, by Cell Therapy, 2019-2028 (US$ Million)
11.1.1.5.5 Spain: GMP Cell Therapy Consumables Market, by End Use, 2019-2028 (US$ Million)
11.1.1.5.6 Spain: GMP Cell Therapy Consumables Market, by Process, 2019-2028 (US$ Million)
11.1.1.6 Rest of Europe: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.6.1 Overview
11.1.1.6.2 Rest of Europe: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.6.3 Rest of Europe: GMP Cell Therapy Consumables Market, by Product, 2019-2028 (US$ Million)
11.1.1.6.4 Rest of Europe: GMP Cell Therapy Consumables Market, by Cell Therapy, 2019-2028 (US$ Million)
11.1.1.6.5 Rest of Europe: GMP Cell Therapy Consumables Market, by End Use, 2019-2028 (US$ Million)
11.1.1.6.6 Rest of Europe: GMP Cell Therapy Consumables Market, by Process, 2019-2028 (US$ Million)
12. GMP Cell Therapy Consumables Market - Industry Landscape
12.1 Overview
12.2 Growth Strategies in GMP Cell Therapy Consumables Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Sartorius AG
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Thermo Fisher Scientific Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Miltenyi Biotec BV & Co KG
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Bio-Techne Corp
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Corning Inc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 FUJIFILM Irvine Scientific Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Lonza Group AG
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 BPS Bioscience Inc
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Merck KGaA
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Global Life Sciences Solutions USA LLC
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Publisher
14.2 Glossary of Terms
Table 1. Germany GMP Cell Therapy Consumables Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany GMP Cell Therapy Consumables Market, by Cell Therapy - Revenue and Forecast to 2028 (US$ Million)
Table 3. Germany GMP Cell Therapy Consumables Market, by End Use - Revenue and Forecast to 2028 (US$ Million)
Table 4. Germany GMP Cell Therapy Consumables Market, by Process - Revenue and Forecast to 2028 (US$ Million)
Table 5. UK GMP Cell Therapy Consumables Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 6. UK GMP Cell Therapy Consumables Market, by Cell Therapy - Revenue and Forecast to 2028 (US$ Million)
Table 7. UK GMP Cell Therapy Consumables Market, by End Use - Revenue and Forecast to 2028 (US$ Million)
Table 8. UK GMP Cell Therapy Consumables Market, by Process - Revenue and Forecast to 2028 (US$ Million)
Table 9. France GMP Cell Therapy Consumables Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 10. France GMP Cell Therapy Consumables Market, by Cell Therapy - Revenue and Forecast to 2028 (US$ Million)
Table 11. France GMP Cell Therapy Consumables Market, by End Use - Revenue and Forecast to 2028 (US$ Million)
Table 12. France GMP Cell Therapy Consumables Market, by Process - Revenue and Forecast to 2028 (US$ Million)
Table 13. Italy GMP Cell Therapy Consumables Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 14. Italy GMP Cell Therapy Consumables Market, by Cell Therapy - Revenue and Forecast to 2028 (US$ Million)
Table 15. Italy GMP Cell Therapy Consumables Market, by End Use - Revenue and Forecast to 2028 (US$ Million)
Table 16. Italy GMP Cell Therapy Consumables Market, by Process - Revenue and Forecast to 2028 (US$ Million)
Table 17. Spain GMP Cell Therapy Consumables Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 18. Spain GMP Cell Therapy Consumables Market, by Cell Therapy - Revenue and Forecast to 2028 (US$ Million)
Table 19. Spain GMP Cell Therapy Consumables Market, by End Use - Revenue and Forecast to 2028 (US$ Million)
Table 20. Spain GMP Cell Therapy Consumables Market, by Process - Revenue and Forecast to 2028 (US$ Million)
Table 21. Rest of Europe GMP Cell Therapy Consumables Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 22. Rest of Europe GMP Cell Therapy Consumables Market, by Cell Therapy - Revenue and Forecast to 2028 (US$ Million)
Table 23. Rest of Europe GMP Cell Therapy Consumables Market, by End Use - Revenue and Forecast to 2028 (US$ Million)
Table 24. Rest of Europe GMP Cell Therapy Consumables Market, by Process - Revenue and Forecast to 2028 (US$ Million)
Table 25. Recent Inorganic Growth Strategies in the GMP Cell Therapy Consumables Market
Table 26. Recent Organic Growth Strategies in GMP Cell Therapy Consumables Market
Table 27. Glossary of Terms
Figure 1. Europe GMP Cell Therapy Consumables Market Segmentation
Figure 2. Europe GMP Cell Therapy Consumables Market, by Country
Figure 3. Europe GMP Cell Therapy Consumables Market Overview
Figure 4. Kits Segment Held the Largest Share of Product Segment in Europe GMP Cell Therapy Consumables Market
Figure 5. Germany Expected to Show Remarkable Growth During Forecast Period
Figure 6. Europe: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. Europe GMP Cell Therapy Consumables Market: Impact Analysis of Drivers and Restraints
Figure 9. Europe GMP Cell Therapy Consumables Market - Revenue Forecast and Analysis - 2019-2028
Figure 10. Europe GMP Cell Therapy Consumables Market Revenue Share, by Product 2021 & 2028 (%)
Figure 11. Kits: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Reagents/ Molecular Biology Reagents: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Growth Factors/Cytokines and Interleukins (Including Protein and Nucleic Acid Purification Buffers): Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. Others: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
Figure 15. Europe GMP Cell Therapy Consumables Market, by Cell Therapy 2021 & 2028 (%)
Figure 16. NK Cell Therapy: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. Stem Cell Therapy: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. T-cell Therapy: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. Other Applications: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Europe GMP Cell Therapy Consumables Market Revenue Share, by End User 2021 & 2028 (%)
Figure 21. Clinical: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Commercial: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. Research: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Europe GMP Cell Therapy Consumables Market Revenue Share, by End User 2021 & 2028 (%)
Figure 25. Cell Collection and Characterization/Sorting and Separation: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Cell Culture and Expansion/Preparation: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. Cryopreservation: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. Cell Processing and Formulation: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. Cell Isolation and Activation: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. Cell Distribution/Handling: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
Figure 31. Process Monitoring and Control/Readministration/Quality Assurance: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
Figure 32. Other: Europe GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. Europe: GMP Cell Therapy Consumables Market, by Key Country - Revenue (2021) (US$ Million)
Figure 34. Europe: GMP Cell Therapy Consumables Market, by Country, 2021 & 2028 (%)
Figure 35. Germany: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
Figure 36. UK: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
Figure 37. France: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
Figure 38. Italy: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
Figure 39. Spain: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
Figure 40. Rest of Europe: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
Figure 41. Growth Strategies in GMP Cell Therapy Consumables Market
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bio-Techne Corp
- BPS Bioscience Inc
- Corning Inc
- FUJIFILM Irvine Scientific Inc
- Global Life Sciences Solutions USA LLC
- Lonza Group AG
- Merck KGaA
- Miltenyi Biotec BV & Co KG
- Sartorius AG
- Thermo Fisher Scientific Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 166 |
| Published | January 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 4827.85 Million |
| Forecasted Market Value ( USD | $ 20569.16 Million |
| Compound Annual Growth Rate | 27.2% |
| Regions Covered | Europe |
